Nucleic Acid Immunity

Advances in Immunology

Volumn 133, Issue , 2017, Pages 121-169

  Hartmann, G ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

ADAR1; Antiviral immunity; cGAMP; cGAS; CpG DNA; CRISPR Cas; DNase; Immune sensing of nucleic acids; Innate immunity; OAS; Oligonucleotide; RIG I; RNAi; RNase H; RNase L; SAMHD1; Sting; TLR3; TLR7; TLR8; TLR9; Trex1

Indexed keywords

2',5' OLIGOADENYLATE SYNTHETASE; ABSENT IN MELANOMA 2 PROTEIN; ADENOSINE DEAMINASE; ADENOSINE DEAMINASE ACTING ON RNA 1; CYCLIC GMP AMP SYNTHASE; DEOXYRIBONUCLEASE; DEOXYRIBONUCLEASE I; DEOXYRIBONUCLEASE II; IFIT1 PROTEIN; IFIT5 PROTEIN; INTERFERON INDUCED HELICASE C DOMAIN CONTAINING PROTEIN 1; LGP2 PROTEIN; NUCLEAR PROTEIN; NUCLEIC ACID; PROTEIN KINASE; PROTEIN KINASE RNA ACTIVATED; RETINOIC ACID INDUCIBLE PROTEIN I; RIBONUCLEASE H; RNA BINDING PROTEIN; SMALL INTERFERING RNA; STERILE ALPHA MOTIF AND HISTIDINE ASPARTATE DOMAIN CONTAINING PROTEIN 1; SYNTHETASE; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TREX1 PROTEIN; UNCLASSIFIED DRUG; PATTERN RECOGNITION RECEPTOR; RETROPOSON;

ADAPTIVE IMMUNITY; ARBOVIRUS; CRISPR CAS SYSTEM; CYTOKINE RELEASE; DNA RNA HYBRIDIZATION; GENE MUTATION; HUMAN; IMMUNITY; INFLAMMATORY DISEASE; INNATE IMMUNITY; INTERFERON PRODUCTION; NONHUMAN; NUCLEIC ACID IMMUNITY; PRIORITY JOURNAL; PROKARYOTE; RETROPOSON; RNA EDITING; RNA INTERFERENCE; VIRAL CLEARANCE; VIREMIA; VIRUS REPLICATION; ANIMAL; ARCHAEON; BACTERIUM; CYTOTOXICITY; GENETICS; IMMUNOLOGY; METABOLISM; MOLECULAR EVOLUTION; VIRUS;

ADAPTIVE IMMUNITY; ANIMALS; ARCHAEA; BACTERIA; CRISPR-CAS SYSTEMS; CYTOTOXICITY, IMMUNOLOGIC; EVOLUTION, MOLECULAR; HUMANS; IMMUNITY, INNATE; NUCLEIC ACIDS; RECEPTORS, PATTERN RECOGNITION; RETROELEMENTS; RNA INTERFERENCE; VIRUSES;

EID: 85008401038     PISSN: 00652776     EISSN: 15578445     Source Type: Book Series    
DOI: 10.1016/bs.ai.2016.11.001     Document Type: Chapter

References (256)

1. Abbas, Y.M., Pichlmair, A., Gorna, M.W., Superti-Furga, G., Nagar, B., Structural basis for viral 5'-PPP-RNA recognition by human IFIT proteins. Nature 494 (2013), 60–64.
2. Abdullah, Z., Schlee, M., Roth, S., Mraheil, M.A., Barchet, W., Bottcher, J., et al. RIG-I detects infection with live Listeria by sensing secreted bacterial nucleic acids. The EMBO Journal 31 (2012), 4153–4164.
3. Ablasser, A., Bauernfeind, F., Hartmann, G., Latz, E., Fitzgerald, K.A., Hornung, V., RIG-I-dependent sensing of poly(dA:dT) through the induction of an RNA polymerase III-transcribed RNA intermediate. Nature Immunology 10 (2009), 1065–1072.
4. Ablasser, A., Goldeck, M., Cavlar, T., Deimling, T., Witte, G., Rohl, I., et al. cGAS produces a 2'-5'-linked cyclic dinucleotide second messenger that activates STING. Nature 498 (2013), 380–384.
5. Ablasser, A., Hemmerling, I., Schmid-Burgk, J.L., Behrendt, R., Roers, A., Hornung, V., TREX1 deficiency triggers cell-autonomous immunity in a cGAS-dependent manner. Journal of Immunology 192 (2014), 5993–5997.
6. Ablasser, A., Schmid-Burgk, J.L., Hemmerling, I., Horvath, G.L., Schmidt, T., Latz, E., et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503 (2013), 530–534.
7. Ahn, J., Gutman, D., Saijo, S., Barber, G.N., STING manifests self DNA-dependent inflammatory disease. Proceedings of the National Academy of Sciences of the United States of America 109 (2012), 19386–19391.
8. Alexopoulou, L., Holt, A.C., Medzhitov, R., Flavell, R.A., Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413 (2001), 732–738.
9. Al-Mayouf, S.M., Sunker, A., Abdwani, R., Abrawi, S.A., Almurshedi, F., Alhashmi, N., et al. Loss-of-function variant in DNASE1L3 causes a familial form of systemic lupus erythematosus. Nature Genetics 43 (2011), 1186–1188.
10. Avalos, A.M., Latz, E., Mousseau, B., Christensen, S.R., Shlomchik, M.J., Lund, F., et al. Differential cytokine production and bystander activation of autoreactive B cells in response to CpG-A and CpG-B oligonucleotides. Journal of Immunology 183 (2009), 6262–6268.
11. Baglioni, C., Minks, M.A., Maroney, P.A., Interferon action may be mediated by activation of a nuclease by pppA2'p5'A2'p5'A. Nature 273 (1978), 684–687.
12. Baldauf, H.M., Pan, X., Erikson, E., Schmidt, S., Daddacha, W., Burggraf, M., et al. SAMHD1 restricts HIV-1 infection in resting CD4(+) T cells. Nature Medicine 18 (2012), 1682–1687.
13. Baranovskii, A.G., Buneva, V.N., Nevinsky, G.A., Human deoxyribonucleases. Biochemistry. Biokhimiia 69 (2004), 587–601.
14. Barber, G.N., STING-dependent cytosolic DNA sensing pathways. Trends in Immunology 35 (2014), 88–93.
15. Barrangou, R., Fremaux, C., Deveau, H., Richards, M., Boyaval, P., Moineau, S., et al. CRISPR provides acquired resistance against viruses in prokaryotes. Science 315 (2007), 1709–1712.
16. Bass, B.L., Weintraub, H., A developmentally regulated activity that unwinds RNA duplexes. Cell 48 (1987), 607–613.
17. Bass, B.L., Weintraub, H., An unwinding activity that covalently modifies its double-stranded RNA substrate. Cell 55 (1988), 1089–1098.
18. Bauer, S., Toll-like receptor 9 processing: The key event in Toll-like receptor 9 activation?. Immunology Letters 149 (2013), 85–87.
19. Baum, R., Sharma, S., Carpenter, S., Li, Q.Z., Busto, P., Fitzgerald, K.A., et al. Cutting edge: AIM2 and endosomal TLRs differentially regulate arthritis and autoantibody production in DNase II-deficient mice. Journal of Immunology 194 (2015), 873–877.
20. Beck-Engeser, G.B., Eilat, D., Wabl, M., An autoimmune disease prevented by anti-retroviral drugs. Retrovirology, 8, 2011, 91.
21. Behrendt, R., Schumann, T., Gerbaulet, A., Nguyen, L.A., Schubert, N., Alexopoulou, D., et al. Mouse SAMHD1 has antiretroviral activity and suppresses a spontaneous cell-intrinsic antiviral response. Cell Reports 4 (2013), 689–696.
22. Beloglazova, N., Flick, R., Tchigvintsev, A., Brown, G., Popovic, A., Nocek, B., et al. Nuclease activity of the human SAMHD1 protein implicated in the Aicardi-Goutieres syndrome and HIV-1 restriction. The Journal of Biological Chemistry 288 (2013), 8101–8110.
23. Bennasser, Y., Le, S.Y., Benkirane, M., Jeang, K.T., Evidence that HIV-1 encodes an siRNA and a suppressor of RNA silencing. Immunity 22 (2005), 607–619.
24. Bernstein, E., Caudy, A.A., Hammond, S.M., Hannon, G.J., Role for a bidentate ribonuclease in the initiation step of RNA interference. Nature 409 (2001), 363–366.
25. Bernstein, E., Kim, S.Y., Carmell, M.A., Murchison, E.P., Alcorn, H., Li, M.Z., et al. Dicer is essential for mouse development. Nature Genetics 35 (2003), 215–217.
26. Besch, R., Poeck, H., Hohenauer, T., Senft, D., Hacker, G., Berking, C., et al. Proapoptotic signaling induced by RIG-I and MDA-5 results in type I interferon-independent apoptosis in human melanoma cells. The Journal of Clinical Investigation 119 (2009), 2399–2411.
27. Brennan-Laun, S.E., Ezelle, H.J., Li, X.L., Hassel, B.A., RNase-L control of cellular mRNAs: Roles in biologic functions and mechanisms of substrate targeting. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 34 (2014), 275–288.
28. Bruns, A.M., Horvath, C.M., LGP2 synergy with MDA5 in RLR-mediated RNA recognition and antiviral signaling. Cytokine 74 (2015), 198–206.
29. Bruns, A.M., Leser, G.P., Lamb, R.A., Horvath, C.M., The innate immune sensor LGP2 activates antiviral signaling by regulating MDA5-RNA interaction and filament assembly. Molecular Cell 55 (2014), 771–781.
30. Burger, K., Gullerova, M., Swiss army knives: Non-canonical functions of nuclear Drosha and Dicer. Nature Reviews. Molecular Cell Biology 16 (2015), 417–430.
31. Busconi, L., Lau, C.M., Tabor, A.S., Uccellini, M.B., Ruhe, Z., Akira, S., et al. DNA and RNA autoantigens as autoadjuvants. Journal of Endotoxin Research 12 (2006), 379–384.
32. Cai, X., Chiu, Y.H., Chen, Z.J., The cGAS-cGAMP-STING pathway of cytosolic DNA sensing and signaling. Molecular Cell 54 (2014), 289–296.
33. Castelli, J.C., Hassel, B.A., Maran, A., Paranjape, J., Hewitt, J.A., Li, X.L., et al. The role of 2'-5' oligoadenylate-activated ribonuclease L in apoptosis. Cell Death and Differentiation 5 (1998), 313–320.
34. Cerritelli, S.M., Crouch, R.J., Ribonuclease H: The enzymes in eukaryotes. The FEBS Journal 276 (2009), 1494–1505.
35. Chan, M.P., Onji, M., Fukui, R., Kawane, K., Shibata, T., Saitoh, S., et al. DNase II-dependent DNA digestion is required for DNA sensing by TLR9. Nature Communications, 6, 2015, 5853.
36. Chon, H., Vassilev, A., DePamphilis, M.L., Zhao, Y., Zhang, J., Burgers, P.M., et al. Contributions of the two accessory subunits, RNASEH2B and RNASEH2C, to the activity and properties of the human RNase H2 complex. Nucleic Acids Research 37 (2009), 96–110.
37. Chu, W.M., Ostertag, D., Li, Z.W., Chang, L., Chen, Y., Hu, Y., et al. JNK2 and IKKbeta are required for activating the innate response to viral infection. Immunity 11 (1999), 721–731.
38. Civril, F., Bennett, M., Moldt, M., Deimling, T., Witte, G., Schiesser, S., et al. The RIG-I ATPase domain structure reveals insights into ATP-dependent antiviral signalling. EMBO Reports 12 (2011), 1127–1134.
39. Clemens, M.J., Elia, A., The double-stranded RNA-dependent protein kinase PKR: Structure and function. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 17 (1997), 503–524.
40. Clemens, M.J., Williams, B.R., Inhibition of cell-free protein synthesis by pppA2'p5'A2'p5'A: A novel oligonucleotide synthesized by interferon-treated L cell extracts. Cell 13 (1978), 565–572.
41. Coch, C., Busch, N., Wimmenauer, V., Hartmann, E., Janke, M., Abdel-Mottaleb, M.M., et al. Higher activation of TLR9 in plasmacytoid dendritic cells by microbial DNA compared with self-DNA based on CpG-specific recognition of phosphodiester DNA. Journal of Leukocyte Biology 86 (2009), 663–670.
42. Crow, Y.J., Hayward, B.E., Parmar, R., Robins, P., Leitch, A., Ali, M., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 cause Aicardi-Goutieres syndrome at the AGS1 locus. Nature Genetics 38 (2006), 917–920.
43. Crow, Y.J., Rehwinkel, J., Aicardi-Goutieres syndrome and related phenotypes: Linking nucleic acid metabolism with autoimmunity. Human Molecular Genetics 18 (2009), R130–R136.
44. Daffis, S., Szretter, K.J., Schriewer, J., Li, J., Youn, S., Errett, J., et al. 2'-O methylation of the viral mRNA cap evades host restriction by IFIT family members. Nature 468 (2010), 452–456.
45. del Toro Duany, Y., Wu, B., Hur, S., MDA5-filament, dynamics and disease. Current Opinion in Virology 12 (2015), 20–25.
46. Diebold, S.S., Kaisho, T., Hemmi, H., Akira, S., Reis e Sousa, C., Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303 (2004), 1529–1531.
47. Doench, J.G., Petersen, C.P., Sharp, P.A., siRNAs can function as miRNAs. Genes & Development 17 (2003), 438–442.
48. Dong, B., Silverman, R.H., A bipartite model of 2-5A-dependent RNase L. The Journal of Biological Chemistry 272 (1997), 22236–22242.
49. Duewell, P., Beller, E., Kirchleitner, S.V., Adunka, T., Bourhis, H., Siveke, J., et al. Targeted activation of melanoma differentiation-associated protein 5 (MDA5) for immunotherapy of pancreatic carcinoma. Oncoimmunology, 4, 2015, e1029698.
50. Duewell, P., Steger, A., Lohr, H., Bourhis, H., Hoelz, H., Kirchleitner, S.V., et al. RIG-I-like helicases induce immunogenic cell death of pancreatic cancer cells and sensitize tumors toward killing by CD8(+) T cells. Cell Death and Differentiation 21 (2014), 1825–1837.
51. El Maadidi, S., Faletti, L., Berg, B., Wenzl, C., Wieland, K., Chen, Z.J., et al. A novel mitochondrial MAVS/Caspase-8 platform links RNA virus-induced innate antiviral signaling to Bax/Bak-independent apoptosis. Journal of Immunology 192 (2014), 1171–1183.
52. Elbashir, S.M., Lendeckel, W., Tuschl, T., RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes & Development 15 (2001), 188–200.
53. Ellermeier, J., Wei, J., Duewell, P., Hoves, S., Stieg, M.R., Adunka, T., et al. Therapeutic efficacy of bifunctional siRNA combining TGF-beta1 silencing with RIG-I activation in pancreatic cancer. Cancer Research 73 (2013), 1709–1720.
54. Evans, C.J., Aguilera, R.J., DNase II: Genes, enzymes and function. Gene 322 (2003), 1–15.
55. Ewald, S.E., Lee, B.L., Lau, L., Wickliffe, K.E., Shi, G.P., Chapman, H.A., et al. The ectodomain of Toll-like receptor 9 is cleaved to generate a functional receptor. Nature 456 (2008), 658–662.
56. Fan, X., Dong, S., Li, Y., Ding, S.W., Wang, M., RIG-I-dependent antiviral immunity is effective against an RNA virus encoding a potent suppressor of RNAi. Biochemical and Biophysical Research Communications 460 (2015), 1035–1040.
57. Farrell, P.J., Sen, G.C., Dubois, M.F., Ratner, L., Slattery, E., Lengyel, P., Interferon action: Two distinct pathways for inhibition of protein synthesis by double-stranded RNA. Proceedings of the National Academy of Sciences of the United States of America 75 (1978), 5893–5897.
58. Feng, G.S., Chong, K., Kumar, A., Williams, B.R., Identification of double-stranded RNA-binding domains in the interferon-induced double-stranded RNA-activated p68 kinase. Proceedings of the National Academy of Sciences of the United States of America 89 (1992), 5447–5451.
59. Fernandes-Alnemri, T., Yu, J.W., Datta, P., Wu, J., Alnemri, E.S., AIM2 activates the inflammasome and cell death in response to cytoplasmic DNA. Nature 458 (2009), 509–513.
60. Flemr, M., Malik, R., Franke, V., Nejepinska, J., Sedlacek, R., Vlahovicek, K., et al. A retrotransposon-driven dicer isoform directs endogenous small interfering RNA production in mouse oocytes. Cell 155 (2013), 807–816.
61. Forsbach, A., Nemorin, J.G., Montino, C., Muller, C., Samulowitz, U., Vicari, A.P., et al. Identification of RNA sequence motifs stimulating sequence-specific TLR8-dependent immune responses. Journal of Immunology 180 (2008), 3729–3738.
62. Gall, A., Treuting, P., Elkon, K.B., Loo, Y.M., Gale, M. Jr., Barber, G.N., et al. Autoimmunity initiates in nonhematopoietic cells and progresses via lymphocytes in an interferon-dependent autoimmune disease. Immunity 36 (2012), 120–131.
63. Ganguly, D., Chamilos, G., Lande, R., Gregorio, J., Meller, S., Facchinetti, V., et al. Self-RNA-antimicrobial peptide complexes activate human dendritic cells through TLR7 and TLR8. The Journal of Experimental Medicine 206 (2009), 1983–1994.
64. Gantier, M.P., Processing of double-stranded RNA in mammalian cells: A direct antiviral role?. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 34 (2014), 469–477.
65. Gao, P., Ascano, M., Wu, Y., Barchet, W., Gaffney, B.L., Zillinger, T., et al. Cyclic [G(2',5')pA(3',5')p] is the metazoan second messenger produced by DNA-activated cyclic GMP-AMP synthase. Cell 153 (2013), 1094–1107.
66. Gao, P., Ascano, M., Zillinger, T., Wang, W., Dai, P., Serganov, A.A., et al. Structure-function analysis of STING activation by c[G(2',5')pA(3',5')p] and targeting by antiviral DMXAA. Cell 154 (2013), 748–762.
67. Gao, D., Li, T., Li, X.D., Chen, X., Li, Q.Z., Wight-Carter, M., et al. Activation of cyclic GMP-AMP synthase by self-DNA causes autoimmune diseases. Proceedings of the National Academy of Sciences of the United States of America 112 (2015), E5699–E5705.
68. Garcia, M.A., Gil, J., Ventoso, I., Guerra, S., Domingo, E., Rivas, C., et al. Impact of protein kinase PKR in cell biology: From antiviral to antiproliferative action. Microbiology and Molecular Biology Reviews: MMBR 70 (2006), 1032–1060.
69. Gehrig, S., Eberle, M.E., Botschen, F., Rimbach, K., Eberle, F., Eigenbrod, T., et al. Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity. The Journal of Experimental Medicine 209 (2012), 225–233.
70. Gehrke, N., Mertens, C., Zillinger, T., Wenzel, J., Bald, T., Zahn, S., et al. Oxidative damage of DNA confers resistance to cytosolic nuclease TREX1 degradation and potentiates STING-dependent immune sensing. Immunity 39 (2013), 482–495.
71. Gelais, C. St., de Silva, S., Amie, S.M., Coleman, C.M., Hoy, H., Hollenbaugh, J.A., et al. SAMHD1 restricts HIV-1 infection in dendritic cells (DCs) by dNTP depletion, but its expression in DCs and primary CD4 + T-lymphocytes cannot be upregulated by interferons. Retrovirology, 9, 2012, 105.
72. George, C.X., John, L., Samuel, C.E., An RNA editor, adenosine deaminase acting on double-stranded RNA (ADAR1). Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 34 (2014), 437–446.
73. Glas, M., Coch, C., Trageser, D., Dassler, J., Simon, M., Koch, P., et al. Targeting the cytosolic innate immune receptors RIG-I and MDA5 effectively counteracts cancer cell heterogeneity in glioblastoma. Stem Cells 31 (2013), 1064–1074.
74. Goldfarb, T., Sberro, H., Weinstock, E., Cohen, O., Doron, S., Charpak-Amikam, Y., et al. BREX is a novel phage resistance system widespread in microbial genomes. The EMBO Journal 34 (2015), 169–183.
75. Goldstone, D.C., Ennis-Adeniran, V., Hedden, J.J., Groom, H.C., Rice, G.I., Christodoulou, E., et al. HIV-1 restriction factor SAMHD1 is a deoxynucleoside triphosphate triphosphohydrolase. Nature 480 (2011), 379–382.
76. Goubau, D., Schlee, M., Deddouche, S., Pruijssers, A.J., Zillinger, T., Goldeck, M., et al. Antiviral immunity via RIG-I-mediated recognition of RNA bearing 5'-diphosphates. Nature 514 (2014), 372–375.
77. Gramberg, T., Kahle, T., Bloch, N., Wittmann, S., Mullers, E., Daddacha, W., et al. Restriction of diverse retroviruses by SAMHD1. Retrovirology, 10, 2013, 26.
78. Gray, E.E., Treuting, P.M., Woodward, J.J., Stetson, D.B., Cutting edge: cGAS is required for lethal autoimmune disease in the Trex1-deficient mouse model of aicardi-goutieres syndrome. Journal of Immunology 195 (2015), 1939–1943.
79. Haasnoot, J., de Vries, W., Geutjes, E.J., Prins, M., de Haan, P., Berkhout, B., The Ebola virus VP35 protein is a suppressor of RNA silencing. PLoS Pathogens, 3, 2007, e86.
80. Habjan, M., Hubel, P., Lacerda, L., Benda, C., Holze, C., Eberl, C.H., et al. Sequestration by IFIT1 impairs translation of 2'O-unmethylated capped RNA. PLoS Pathogens, 9, 2013, e1003663.
81. Hakkim, A., Furnrohr, B.G., Amann, K., Laube, B., Abed, U.A., Brinkmann, V., et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proceedings of the National Academy of Sciences of the United States of America 107 (2010), 9813–9818.
82. Han, Y., Donovan, J., Rath, S., Whitney, G., Chitrakar, A., Korennykh, A., Structure of human RNase L reveals the basis for regulated RNA decay in the IFN response. Science 343 (2014), 1244–1248.
83. Harris, R.S., Dudley, J.P., APOBECs and virus restriction. Virology 479–480 (2015), 131–145.
84. Hartman, Z.C., Kiang, A., Everett, R.S., Serra, D., Yang, X.Y., Clay, T.M., et al. Adenovirus infection triggers a rapid, MyD88-regulated transcriptome response critical to acute-phase and adaptive immune responses in vivo. Journal of Virology 81 (2007), 1796–1812.
85. Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., et al. Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. European Journal of Immunology 33 (2003), 1633–1641.
86. Hartmann, G., Krieg, A.M., CpG DNA and LPS induce distinct patterns of activation in human monocytes. Gene Therapy 6 (1999), 893–903.
87. Hartmann, G., Krieg, A.M., Mechanism and function of a newly identified CpG DNA motif in human primary B cells. Journal of Immunology 164 (2000), 944–953.
88. Hartmann, G., Weeratna, R.D., Ballas, Z.K., Payette, P., Blackwell, S., Suparto, I., et al. Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo. Journal of Immunology 164 (2000), 1617–1624.
89. Hartmann, G., Weiner, G.J., Krieg, A.M., CpG DNA: A potent signal for growth, activation, and maturation of human dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 96 (1999), 9305–9310.
90. He, Y., Franchi, L., Nunez, G., The protein kinase PKR is critical for LPS-induced iNOS production but dispensable for inflammasome activation in macrophages. European Journal of Immunology 43 (2013), 1147–1152.
91. Heckelsmiller, K., Rall, K., Beck, S., Schlamp, A., Seiderer, J., Jahrsdorfer, B., et al. Peritumoral CpG DNA elicits a coordinated response of CD8 T cells and innate effectors to cure established tumors in a murine colon carcinoma model. Journal of Immunology 169 (2002), 3892–3899.
92. Heil, F., Hemmi, H., Hochrein, H., Ampenberger, F., Kirschning, C., Akira, S., et al. Species-specific recognition of single-stranded RNA via toll-like receptor 7 and 8. Science 303 (2004), 1526–1529.
93. Hemmi, H., Takeuchi, O., Kawai, T., Kaisho, T., Sato, S., Sanjo, H., et al. A Toll-like receptor recognizes bacterial DNA. Nature 408 (2000), 740–745.
94. Herzner, A.M., Hagmann, C.A., Goldeck, M., Wolter, S., Kubler, K., Wittmann, S., et al. Sequence-specific activation of the DNA sensor cGAS by Y-form DNA structures as found in primary HIV-1 cDNA. Nature Immunology 16 (2015), 1025–1033.
95. Hochheiser, K., Klein, M., Gottschalk, C., Hoss, F., Scheu, S., Coch, C., et al. Cutting edge: The RIG-I ligand 3pRNA potently improves CTL cross-priming and facilitates antiviral vaccination. Journal of Immunology 196 (2016), 2439–2443.
96. Hogg, M., Paro, S., Keegan, L.P., O'Connell, M.A., RNA editing by mammalian ADARs. Advances in Genetics 73 (2011), 87–120.
97. Hollenbaugh, J.A., Gee, P., Baker, J., Daly, M.B., Amie, S.M., Tate, J., et al. Host factor SAMHD1 restricts DNA viruses in non-dividing myeloid cells. PLoS Pathogens, 9, 2013, e1003481.
98. Hornung, V., Ablasser, A., Charrel-Dennis, M., Bauernfeind, F., Horvath, G., Caffrey, D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature 458 (2009), 514–518.
99. Hornung, V., Ellegast, J., Kim, S., Brzozka, K., Jung, A., Kato, H., et al. 5'-Triphosphate RNA is the ligand for RIG-I. Science 314 (2006), 994–997.
100. Hornung, V., Guenthner-Biller, M., Bourquin, C., Ablasser, A., Schlee, M., Uematsu, S., et al. Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7. Nature Medicine 11 (2005), 263–270.
101. Hornung, V., Hartmann, R., Ablasser, A., Hopfner, K.P., OAS proteins and cGAS: Unifying concepts in sensing and responding to cytosolic nucleic acids. Nature Reviews. Immunology 14 (2014), 521–528.
102. Hornung, V., Latz, E., Intracellular DNA recognition. Nature Reviews. Immunology 10 (2010), 123–130.
103. Hornung, V., Rothenfusser, S., Britsch, S., Krug, A., Jahrsdorfer, B., Giese, T., et al. Quantitative expression of toll-like receptor 1–10 mRNA in cellular subsets of human peripheral blood mononuclear cells and sensitivity to CpG oligodeoxynucleotides. Journal of Immunology 168 (2002), 4531–4537.
104. Hoss, M., Robins, P., Naven, T.J., Pappin, D.J., Sgouros, J., Lindahl, T., A human DNA editing enzyme homologous to the Escherichia coli DnaQ/MutD protein. The EMBO Journal 18 (1999), 3868–3875.
105. Hovanessian, A.G., Brown, R.E., Kerr, I.M., Synthesis of low molecular weight inhibitor of protein synthesis with enzyme from interferon-treated cells. Nature 268 (1977), 537–540.
106. Hrecka, K., Hao, C., Gierszewska, M., Swanson, S.K., Kesik-Brodacka, M., Srivastava, S., et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474 (2011), 658–661.
107. Huang, H., Zeqiraj, E., Dong, B., Jha, B.K., Duffy, N.M., Orlicky, S., et al. Dimeric structure of pseudokinase RNase L bound to 2-5A reveals a basis for interferon-induced antiviral activity. Molecular Cell 53 (2014), 221–234.
108. Hyde, J.L., Diamond, M.S., Innate immune restriction and antagonism of viral RNA lacking 2-O methylation. Virology 479–480 (2015), 66–74.
109. Isaacs, A., Particle counts and infectivity titrations for animal viruses. Advances in Virus Research 4 (1957), 111–158.
110. Isaacs, A., Cox, R.A., Rotem, Z., Foreign nucleic acids as the stimulus to make interferon. Lancet 2 (1963), 113–116.
111. Iwakawa, H.O., Tomari, Y., The functions of MicroRNAs: mRNA decay and translational repression. Trends in Cell Biology 25 (2015), 651–665.
112. Jakobs, C., Perner, S., Hornung, V., AIM2 drives joint inflammation in a self-DNA triggered model of chronic polyarthritis. PloS One, 10, 2015, e0131702.
113. Jang, M.A., Kim, E.K., Now, H., Nguyen, N.T., Kim, W.J., Yoo, J.Y., et al. Mutations in DDX58, which encodes RIG-I, cause atypical singleton-merten syndrome. American Journal of Human Genetics 96 (2015), 266–274.
114. Jeong, H.S., Backlund, P.S., Chen, H.C., Karavanov, A.A., Crouch, R.J., RNase H2 of Saccharomyces cerevisiae is a complex of three proteins. Nucleic Acids Research 32 (2004), 407–414.
115. Jiang, F., Ramanathan, A., Miller, M.T., Tang, G.Q., Gale, M. Jr., Patel, S.S., et al. Structural basis of RNA recognition and activation by innate immune receptor RIG-I. Nature 479 (2011), 423–427.
116. Jin, T., Perry, A., Jiang, J., Smith, P., Curry, J.A., Unterholzner, L., et al. Structures of the HIN domain:DNA complexes reveal ligand binding and activation mechanisms of the AIM2 inflammasome and IFI16 receptor. Immunity 36 (2012), 561–571.
117. Jockel, S., Nees, G., Sommer, R., Zhao, Y., Cherkasov, D., Hori, H., et al. The 2'-O-methylation status of a single guanosine controls transfer RNA-mediated Toll-like receptor 7 activation or inhibition. The Journal of Experimental Medicine 209 (2012), 235–241.
118. Judge, A.D., Sood, V., Shaw, J.R., Fang, D., McClintock, K., MacLachlan, I., Sequence-dependent stimulation of the mammalian innate immune response by synthetic siRNA. Nature Biotechnology 23 (2005), 457–462.
119. Junt, T., Barchet, W., Translating nucleic acid-sensing pathways into therapies. Nature Reviews. Immunology 15 (2015), 529–544.
120. Kariko, K., Buckstein, M., Ni, H., Weissman, D., Suppression of RNA recognition by Toll-like receptors: The impact of nucleoside modification and the evolutionary origin of RNA. Immunity 23 (2005), 165–175.
121. Kato, H., Fujita, T., RIG-I-like receptors and autoimmune diseases. Current Opinion in Immunology 37 (2015), 40–45.
122. Kato, H., Sato, S., Yoneyama, M., Yamamoto, M., Uematsu, S., Matsui, K., et al. Cell type-specific involvement of RIG-I in antiviral response. Immunity 23 (2005), 19–28.
123. Kawane, K., Ohtani, M., Miwa, K., Kizawa, T., Kanbara, Y., Yoshioka, Y., et al. Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature 443 (2006), 998–1002.
124. Kerkmann, M., Costa, L.T., Richter, C., Rothenfusser, S., Battiany, J., Hornung, V., et al. Spontaneous formation of nucleic acid-based nanoparticles is responsible for high interferon-alpha induction by CpG-A in plasmacytoid dendritic cells. The Journal of Biological Chemistry 280 (2005), 8086–8093.
125. Kerkmann, M., Rothenfusser, S., Hornung, V., Towarowski, A., Wagner, M., Sarris, A., et al. Activation with CpG-A and CpG-B oligonucleotides reveals two distinct regulatory pathways of type I IFN synthesis in human plasmacytoid dendritic cells. Journal of Immunology 170 (2003), 4465–4474.
126. Kim, S., Kaiser, V., Beier, E., Bechheim, M., Guenthner-Biller, M., Ablasser, A., et al. Self-priming determines high type I IFN production by plasmacytoid dendritic cells. European Journal of Immunology 44 (2014), 807–818.
127. Kim, B., Nguyen, L.A., Daddacha, W., Hollenbaugh, J.A., Tight interplay among SAMHD1 protein level, cellular dNTP levels, and HIV-1 proviral DNA synthesis kinetics in human primary monocyte-derived macrophages. The Journal of Biological Chemistry 287 (2012), 21570–21574.
128. Kim, U., Wang, Y., Sanford, T., Zeng, Y., Nishikura, K., Molecular cloning of cDNA for double-stranded RNA adenosine deaminase, a candidate enzyme for nuclear RNA editing. Proceedings of the National Academy of Sciences of the United States of America 91 (1994), 11457–11461.
129. Kim, E.T., White, T.E., Brandariz-Nunez, A., Diaz-Griffero, F., Weitzman, M.D., SAMHD1 restricts herpes simplex virus 1 in macrophages by limiting DNA replication. Journal of Virology 87 (2013), 12949–12956.
130. Kohlway, A., Luo, D., Rawling, D.C., Ding, S.C., Pyle, A.M., Defining the functional determinants for RNA surveillance by RIG-I. EMBO Reports 14 (2013), 772–779.
131. Kowalinski, E., Lunardi, T., McCarthy, A.A., Louber, J., Brunel, J., Grigorov, B., et al. Structural basis for the activation of innate immune pattern-recognition receptor RIG-I by viral RNA. Cell 147 (2011), 423–435.
132. Krieg, A.M., Yi, A.K., Matson, S., Waldschmidt, T.J., Bishop, G.A., Teasdale, R., et al. CpG motifs in bacterial DNA trigger direct B-cell activation. Nature 374 (1995), 546–549.
133. Krug, A., Rothenfusser, S., Selinger, S., Bock, C., Kerkmann, M., Battiany, J., et al. CpG-A oligonucleotides induce a monocyte-derived dendritic cell-like phenotype that preferentially activates CD8 T cells. Journal of Immunology 170 (2003), 3468–3477.
134. Kubler, K., Gehrke, N., Riemann, S., Bohnert, V., Zillinger, T., Hartmann, E., et al. Targeted activation of RNA helicase retinoic acid-inducible gene-I induces proimmunogenic apoptosis of human ovarian cancer cells. Cancer Research 70 (2010), 5293–5304.
135. Kumar, A., Haque, J., Lacoste, J., Hiscott, J., Williams, B.R., Double-stranded RNA-dependent protein kinase activates transcription factor NF-kappa B by phosphorylating I kappa B. Proceedings of the National Academy of Sciences of the United States of America 91 (1994), 6288–6292.
136. Kumar, S., Ingle, H., Mishra, S., Mahla, R.S., Kumar, A., Kawai, T., et al. IPS-1 differentially induces TRAIL, BCL2, BIRC3 and PRKCE in type I interferons-dependent and -independent anticancer activity. Cell Death & Disease, 6, 2015, e1758.
137. Laguette, N., Sobhian, B., Casartelli, N., Ringeard, M., Chable-Bessia, C., Segeral, E., et al. SAMHD1 is the dendritic- and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474 (2011), 654–657.
138. Lahouassa, H., Daddacha, W., Hofmann, H., Ayinde, D., Logue, E.C., Dragin, L., et al. SAMHD1 restricts the replication of human immunodeficiency virus type 1 by depleting the intracellular pool of deoxynucleoside triphosphates. Nature Immunology 13 (2012), 223–228.
139. Lan, Y.Y., Londono, D., Bouley, R., Rooney, M.S., Hacohen, N., Dnase2a deficiency uncovers lysosomal clearance of damaged nuclear DNA via autophagy. Cell Reports 9 (2014), 180–192.
140. Lassig, C., Matheisl, S., Sparrer, K.M., de Oliveira Mann, C.C., Moldt, M., Patel, J.R., et al. ATP hydrolysis by the viral RNA sensor RIG-I prevents unintentional recognition of self-RNA. eLife, 4, 2015, e10859.
141. Latz, E., Schoenemeyer, A., Visintin, A., Fitzgerald, K.A., Monks, B.G., Knetter, C.F., et al. TLR9 signals after translocating from the ER to CpG DNA in the lysosome. Nature Immunology 5 (2004), 190–198.
142. Lecellier, C.H., Dunoyer, P., Arar, K., Lehmann-Che, J., Eyquem, S., Himber, C., et al. A cellular microRNA mediates antiviral defense in human cells. Science 308 (2005), 557–560.
143. Lee, Y., Ahn, C., Han, J., Choi, H., Kim, J., Yim, J., et al. The nuclear RNase III Drosha initiates microRNA processing. Nature 425 (2003), 415–419.
144. Lee-Kirsch, M.A., Chowdhury, D., Harvey, S., Gong, M., Senenko, L., Engel, K., et al. A mutation in TREX1 that impairs susceptibility to granzyme A-mediated cell death underlies familial chilblain lupus. Journal of Molecular Medicine 85 (2007), 531–537.
145. Lee-Kirsch, M.A., Gong, M., Chowdhury, D., Senenko, L., Engel, K., Lee, Y.A., et al. Mutations in the gene encoding the 3'-5' DNA exonuclease TREX1 are associated with systemic lupus erythematosus. Nature Genetics 39 (2007), 1065–1067.
146. Levin, D., London, I.M., Regulation of protein synthesis: Activation by double-stranded RNA of a protein kinase that phosphorylates eukaryotic initiation factor 2. Proceedings of the National Academy of Sciences of the United States of America 75 (1978), 1121–1125.
147. Li, W.X., Li, H., Lu, R., Li, F., Dus, M., Atkinson, P., et al. Interferon antagonist proteins of influenza and vaccinia viruses are suppressors of RNA silencing. Proceedings of the National Academy of Sciences of the United States of America 101 (2004), 1350–1355.
148. Li, Y., Lu, J., Han, Y., Fan, X., Ding, S.W., RNA interference functions as an antiviral immunity mechanism in mammals. Science 342 (2013), 231–234.
149. Li, N., Zhang, W., Cao, X., Identification of human homologue of mouse IFN-gamma induced protein from human dendritic cells. Immunology Letters 74 (2000), 221–224.
150. Liddicoat, B.J., Piskol, R., Chalk, A.M., Ramaswami, G., Higuchi, M., Hartner, J.C., et al. RNA editing by ADAR1 prevents MDA5 sensing of endogenous dsRNA as nonself. Science 349 (2015), 1115–1120.
151. Lindenmann, J., Burke, D.C., Isaacs, A., Studies on the production, mode of action and properties of interferon. British Journal of Experimental Pathology 38 (1957), 551–562.
152. Liu, L., Botos, I., Wang, Y., Leonard, J.N., Shiloach, J., Segal, D.M., et al. Structural basis of toll-like receptor 3 signaling with double-stranded RNA. Science 320 (2008), 379–381.
153. Lu, S., Cullen, B.R., Adenovirus VA1 noncoding RNA can inhibit small interfering RNA and MicroRNA biogenesis. Journal of Virology 78 (2004), 12868–12876.
154. Lu, A., Kabaleeswaran, V., Fu, T., Magupalli, V.G., Wu, H., Crystal structure of the F27G AIM2 PYD mutant and similarities of its self-association to DED/DED interactions. Journal of Molecular Biology 426 (2014), 1420–1427.
155. Lu, A., Li, Y., Yin, Q., Ruan, J., Yu, X., Egelman, E., et al. Plasticity in PYD assembly revealed by cryo-EM structure of the PYD filament of AIM2. Cell Discovery, 1, 2015, 15013.
156. Lu, A., Magupalli, V.G., Ruan, J., Yin, Q., Atianand, M.K., Vos, M.R., et al. Unified polymerization mechanism for the assembly of ASC-dependent inflammasomes. Cell 156 (2014), 1193–1206.
157. Lu, B., Nakamura, T., Inouye, K., Li, J., Tang, Y., Lundback, P., et al. Novel role of PKR in inflammasome activation and HMGB1 release. Nature 488 (2012), 670–674.
158. Luo, D., Ding, S.C., Vela, A., Kohlway, A., Lindenbach, B.D., Pyle, A.M., Structural insights into RNA recognition by RIG-I. Cell 147 (2011), 409–422.
159. Luria, S.E., Human, M.L., A nonhereditary, host-induced variation of bacterial viruses. Journal of Bacteriology 64 (1952), 557–569.
160. Mackenzie, K.J., Carroll, P., Lettice, L., Tarnauskaite, Z., Reddy, K., Dix, F., et al. Ribonuclease H2 mutations induce a cGAS/STING-dependent innate immune response. The EMBO Journal 35 (2016), 831–844.
161. Maggi, L.B. Jr., Heitmeier, M.R., Scheuner, D., Kaufman, R.J., Buller, R.M., Corbett, J.A., Potential role of PKR in double-stranded RNA-induced macrophage activation. The EMBO Journal 19 (2000), 3630–3638.
162. Mankan, A.K., Schmidt, T., Chauhan, D., Goldeck, M., Honing, K., Gaidt, M., et al. Cytosolic RNA:DNA hybrids activate the cGAS-STING axis. The EMBO Journal 33 (2014), 2937–2946.
163. Marq, J.B., Hausmann, S., Veillard, N., Kolakofsky, D., Garcin, D., Short double-stranded RNAs with an overhanging 5' ppp-nucleotide, as found in arenavirus genomes, act as RIG-I decoys. The Journal of Biological Chemistry 286 (2010), 6108–6116.
164. Marq, J.B., Kolakofsky, D., Garcin, D., Unpaired 5' ppp-nucleotides, as found in arenavirus double-stranded RNA panhandles, are not recognized by RIG-I. The Journal of Biological Chemistry 285 (2010), 18208–18216.
165. Marraffini, L.A., Sontheimer, E.J., CRISPR interference: RNA-directed adaptive immunity in bacteria and archaea. Nature Reviews. Genetics 11 (2010), 181–190.
166. Marshak-Rothstein, A., Tolling for autoimmunity-prime time for 7. Immunity 25 (2006), 397–399.
167. Matsumoto, M., Kikkawa, S., Kohase, M., Miyake, K., Seya, T., Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling. Biochemical and Biophysical Research Communications 293 (2002), 1364–1369.
168. McAllister, C.S., Taghavi, N., Samuel, C.E., Protein kinase PKR amplification of interferon beta induction occurs through initiation factor eIF-2alpha-mediated translational control. The Journal of Biological Chemistry 287 (2012), 36384–36392.
169. Meister, G., Landthaler, M., Patkaniowska, A., Dorsett, Y., Teng, G., Tuschl, T., Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs. Molecular Cell 15 (2004), 185–197.
170. Melchjorsen, J., Kristiansen, H., Christiansen, R., Rintahaka, J., Matikainen, S., Paludan, S.R., et al. Differential regulation of the OASL and OAS1 genes in response to viral infections. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 29 (2009), 199–207.
171. Morita, M., Stamp, G., Robins, P., Dulic, A., Rosewell, I., Hrivnak, G., et al. Gene-targeted mice lacking the Trex1 (DNase III) 3'- > 5' DNA exonuclease develop inflammatory myocarditis. Molecular and Cellular Biology 24 (2004), 6719–6727.
172. Nallagatla, S.R., Hwang, J., Toroney, R., Zheng, X., Cameron, C.E., Bevilacqua, P.C., 5'-Triphosphate-dependent activation of PKR by RNAs with short stem-loops. Science 318 (2007), 1455–1458.
173. Napirei, M., Karsunky, H., Zevnik, B., Stephan, H., Mannherz, H.G., Moroy, T., Features of systemic lupus erythematosus in Dnase1-deficient mice. Nature Genetics 25 (2000), 177–181.
174. Napirei, M., Ludwig, S., Mezrhab, J., Klockl, T., Mannherz, H.G., Murine serum nucleases—Contrasting effects of plasmin and heparin on the activities of DNase1 and DNase1-like 3 (DNase1l3). The FEBS Journal 276 (2009), 1059–1073.
175. Nathans, D., Smith, H.O., Restriction endonucleases in the analysis and restructuring of DNA molecules. Annual Review of Biochemistry 44 (1975), 273–293.
176. Nishikura, K., A-to-I editing of coding and non-coding RNAs by ADARs. Nature Reviews. Molecular Cell Biology 17 (2016), 83–96.
177. Ohto, U., Shibata, T., Tanji, H., Ishida, H., Krayukhina, E., Uchiyama, S., et al. Structural basis of CpG and inhibitory DNA recognition by Toll-like receptor 9. Nature 520 (2015), 702–705.
178. Oka, T., Hikoso, S., Yamaguchi, O., Taneike, M., Takeda, T., Tamai, T., et al. Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure. Nature 485 (2012), 251–255.
179. Onji, M., Kanno, A., Saitoh, S., Fukui, R., Motoi, Y., Shibata, T., et al. An essential role for the N-terminal fragment of Toll-like receptor 9 in DNA sensing. Nature Communications, 4, 2013, 1949.
180. Ota, H., Sakurai, M., Gupta, R., Valente, L., Wulff, B.E., Ariyoshi, K., et al. ADAR1 forms a complex with dicer to promote microRNA processing and RNA-induced gene silencing. Cell 153 (2013), 575–589.
181. Parameswaran, P., Sklan, E., Wilkins, C., Burgon, T., Samuel, M.A., Lu, R., et al. Six RNA viruses and forty-one hosts: Viral small RNAs and modulation of small RNA repertoires in vertebrate and invertebrate systems. PLoS Pathogens, 6, 2010, e1000764.
182. Park, B., Brinkmann, M.M., Spooner, E., Lee, C.C., Kim, Y.M., Ploegh, H.L., Proteolytic cleavage in an endolysosomal compartment is required for activation of Toll-like receptor 9. Nature Immunology 9 (2008), 1407–1414.
183. Pauls, E., Ruiz, A., Riveira-Munoz, E., Permanyer, M., Badia, R., Clotet, B., et al. p21 regulates the HIV-1 restriction factor SAMHD1. Proceedings of the National Academy of Sciences of the United States of America 111 (2014), E1322–E1324.
184. Pawaria, S., Moody, K., Busto, P., Nundel, K., Choi, C.H., Ghayur, T., et al. Cutting Edge: DNase II deficiency prevents activation of autoreactive B cells by double-stranded DNA endogenous ligands. Journal of Immunology 194 (2015), 1403–1407.
185. Pelka, K., Shibata, T., Miyake, K., Latz, E., Nucleic acid-sensing TLRs and autoimmunity: Novel insights from structural and cell biology. Immunological Reviews 269 (2016), 60–75.
186. Peter, M.E., Kubarenko, A.V., Weber, A.N., Dalpke, A.H., Identification of an N-terminal recognition site in TLR9 that contributes to CpG-DNA-mediated receptor activation. Journal of Immunology 182 (2009), 7690–7697.
187. Pfeffer, S., Sewer, A., Lagos-Quintana, M., Sheridan, R., Sander, C., Grasser, F.A., et al. Identification of microRNAs of the herpesvirus family. Nature Methods 2 (2005), 269–276.
188. Pichlmair, A., Lassnig, C., Eberle, C.A., Gorna, M.W., Baumann, C.L., Burkard, T.R., et al. IFIT1 is an antiviral protein that recognizes 5'-triphosphate RNA. Nature Immunology 12 (2011), 624–630.
189. Pichlmair, A., Schulz, O., Tan, C.P., Naslund, T.I., Liljestrom, P., Weber, F., et al. RIG-I-mediated antiviral responses to single-stranded RNA bearing 5'-phosphates. Science 314 (2006), 997–1001.
190. Pichlmair, A., Schulz, O., Tan, C.P., Rehwinkel, J., Kato, H., Takeuchi, O., et al. Activation of MDA5 requires higher-order RNA structures generated during virus infection. Journal of Virology 83 (2009), 10761–10769.
191. Poeck, H., Bscheider, M., Gross, O., Finger, K., Roth, S., Rebsamen, M., et al. Recognition of RNA virus by RIG-I results in activation of CARD9 and inflammasome signaling for interleukin 1 beta production. Nature Immunology 11 (2010), 63–69.
192. Pohar, J., Pirher, N., Bencina, M., Mancek-Keber, M., Jerala, R., The role of UNC93B1 protein in surface localization of TLR3 receptor and in cell priming to nucleic acid agonists. The Journal of Biological Chemistry 288 (2013), 442–454.
193. Pokatayev, V., Hasin, N., Chon, H., Cerritelli, S.M., Sakhuja, K., Ward, J.M., et al. RNase H2 catalytic core Aicardi-Goutieres syndrome-related mutant invokes cGAS-STING innate immune-sensing pathway in mice. The Journal of Experimental Medicine 213 (2016), 329–336.
194. Pothlichet, J., Meunier, I., Davis, B.K., Ting, J.P., Skamene, E., von Messling, V., et al. Type I IFN triggers RIG-I/TLR3/NLRP3-dependent inflammasome activation in influenza A virus infected cells. PLoS Pathogens, 9, 2013, e1003256.
195. Powell, R.D., Holland, P.J., Hollis, T., Perrino, F.W., Aicardi-Goutieres syndrome gene and HIV-1 restriction factor SAMHD1 is a dGTP-regulated deoxynucleotide triphosphohydrolase. The Journal of Biological Chemistry 286 (2011), 43596–43600.
196. Rasmussen, A.L., Katze, M.G., Genomic signatures of emerging viruses: A new era of systems epidemiology. Cell Host & Microbe 19 (2016), 611–618.
197. Rebouillat, D., Hovanessian, A.G., The human 2',5'-oligoadenylate synthetase family: Interferon-induced proteins with unique enzymatic properties. Journal of Interferon & Cytokine Research: The Official Journal of the International Society for Interferon and Cytokine Research 19 (1999), 295–308.
198. Rehwinkel, J., Maelfait, J., Bridgeman, A., Rigby, R., Hayward, B., Liberatore, R.A., et al. SAMHD1-dependent retroviral control and escape in mice. The EMBO Journal 32 (2013), 2454–2462.
199. Rehwinkel, J., Tan, C.P., Goubau, D., Schulz, O., Pichlmair, A., Bier, K., et al. RIG-I detects viral genomic RNA during negative-strand RNA virus infection. Cell 140 (2010), 397–408.
200. Rice, G.I., Bond, J., Asipu, A., Brunette, R.L., Manfield, I.W., Carr, I.M., et al. Mutations involved in Aicardi-Goutieres syndrome implicate SAMHD1 as regulator of the innate immune response. Nature Genetics 41 (2009), 829–832.
201. Rice, G.I., Kasher, P.R., Forte, G.M., Mannion, N.M., Greenwood, S.M., Szynkiewicz, M., et al. Mutations in ADAR1 cause Aicardi-Goutieres syndrome associated with a type I interferon signature. Nature Genetics 44 (2012), 1243–1248.
202. Rice, G., Patrick, T., Parmar, R., Taylor, C.F., Aeby, A., Aicardi, J., et al. Clinical and molecular phenotype of Aicardi-Goutieres syndrome. American Journal of Human Genetics 81 (2007), 713–725.
203. Richards, A., van den Maagdenberg, A.M., Jen, J.C., Kavanagh, D., Bertram, P., Spitzer, D., et al. C-terminal truncations in human 3'-5' DNA exonuclease TREX1 cause autosomal dominant retinal vasculopathy with cerebral leukodystrophy. Nature Genetics 39 (2007), 1068–1070.
204. Rigby, R.E., Webb, L.M., Mackenzie, K.J., Li, Y., Leitch, A., Reijns, M.A., et al. RNA:DNA hybrids are a novel molecular pattern sensed by TLR9. The EMBO Journal 33 (2014), 542–558.
205. Roberts, T.L., Idris, A., Dunn, J.A., Kelly, G.M., Burnton, C.M., Hodgson, S., et al. HIN-200 proteins regulate caspase activation in response to foreign cytoplasmic DNA. Science 323 (2009), 1057–1060.
206. Rothenfusser, S., Goutagny, N., DiPerna, G., Gong, M., Monks, B.G., Schoenemeyer, A., et al. The RNA helicase Lgp2 inhibits TLR-independent sensing of viral replication by retinoic acid-inducible gene-I. Journal of Immunology 175 (2005), 5260–5268.
207. Rothenfusser, S., Hornung, V., Ayyoub, M., Britsch, S., Towarowski, A., Krug, A., et al. CpG-A and CpG-B oligonucleotides differentially enhance human peptide-specific primary and memory CD8 + T-cell responses in vitro. Blood 103 (2004), 2162–2169.
208. Ryoo, J., Choi, J., Oh, C., Kim, S., Seo, M., Kim, S.Y., et al. The ribonuclease activity of SAMHD1 is required for HIV-1 restriction. Nature Medicine 20 (2014), 936–941.
209. Samejima, K., Earnshaw, W.C., Trashing the genome: The role of nucleases during apoptosis. Nature Reviews. Molecular Cell Biology 6 (2005), 677–688.
210. Schlee, M., Hartmann, E., Coch, C., Wimmenauer, V., Janke, M., Barchet, W., et al. Approaching the RNA ligand for RIG-I?. Immunological Reviews 227 (2009), 66–74.
211. Schlee, M., Roth, A., Hornung, V., Hagmann, C.A., Wimmenauer, V., Barchet, W., et al. Recognition of 5' triphosphate by RIG-I helicase requires short blunt double-stranded RNA as contained in panhandle of negative-strand virus. Immunity 31 (2009), 25–34.
212. Schnettler, E., Sterken, M.G., Leung, J.Y., Metz, S.W., Geertsema, C., Goldbach, R.W., et al. Noncoding flavivirus RNA displays RNA interference suppressor activity in insect and Mammalian cells. Journal of Virology 86 (2012), 13486–13500.
213. Schnurr, M., Duewell, P., Breaking tumor-induced immunosuppression with 5'-triphosphate siRNA silencing TGFbeta and activating RIG-I. Oncoimmunology, 2, 2013, e24170.
214. Schnurr, M., Duewell, P., Induction of immunogenic cell death by targeting RIG-I-like helicases in pancreatic cancer. Oncoimmunology, 3, 2014, e955687.
215. Schoggins, J.W., Wilson, S.J., Panis, M., Murphy, M.Y., Jones, C.T., Bieniasz, P., et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472 (2011), 481–485.
216. Schuberth-Wagner, C., Ludwig, J., Bruder, A.K., Herzner, A.M., Zillinger, T., Goldeck, M., et al. A conserved histidine in the RNA sensor RIG-I controls immune tolerance to N1-2'O-methylated self RNA. Immunity 43 (2015), 41–51.
217. Sen, G.C., Taira, H., Lengyel, P., Interferon, double-stranded RNA, and protein phosphorylation. Characteristics of a double-stranded RNA-activated protein kinase system partially purified from interferon treated Ehrlich ascites tumor cells. The Journal of Biological Chemistry 253 (1978), 5915–5921.
218. Seo, G.J., Kincaid, R.P., Phanaksri, T., Burke, J.M., Pare, J.M., Cox, J.E., et al. Reciprocal inhibition between intracellular antiviral signaling and the RNAi machinery in mammalian cells. Cell Host & Microbe 14 (2013), 435–445.
219. Silverman, R.H., Viral encounters with 2',5'-oligoadenylate synthetase and RNase L during the interferon antiviral response. Journal of Virology 81 (2007), 12720–12729.
220. Simon, V., Bloch, N., Landau, N.R., Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nature Immunology 16 (2015), 546–553.
221. Sioud, M., Single-stranded small interfering RNA are more immunostimulatory than their double-stranded counterparts: A central role for 2'-hydroxyl uridines in immune responses. European Journal of Immunology 36 (2006), 1222–1230.
222. Stein, H., Hausen, P., Enzyme from calf thymus degrading the RNA moiety of DNA-RNA hybrids: Effect on DNA-dependent RNA polymerase. Science 166 (1969), 393–395.
223. Stetson, D.B., Ko, J.S., Heidmann, T., Medzhitov, R., Trex1 prevents cell-intrinsic initiation of autoimmunity. Cell 134 (2008), 587–598.
224. Svoboda, P., Renaissance of mammalian endogenous RNAi. FEBS Letters 588 (2014), 2550–2556.
225. Szittya, G., Burgyan, J., RNA interference-mediated intrinsic antiviral immunity in plants. Current Topics in Microbiology and Immunology 371 (2013), 153–181.
226. Taylor, M.J., Bandi, C., Hoerauf, A., Wolbachia bacterial endosymbionts of filarial nematodes. Advances in Parasitology 60 (2005), 245–284.
227. Thomis, D.C., Doohan, J.P., Samuel, C.E., Mechanism of interferon action: cDNA structure, expression, and regulation of the interferon-induced, RNA-dependent P1/eIF-2 alpha protein kinase from human cells. Virology 188 (1992), 33–46.
228. Thomis, D.C., Samuel, C.E., Mechanism of interferon action: Autoregulation of RNA-dependent P1/eIF-2 alpha protein kinase (PKR) expression in transfected mammalian cells. Proceedings of the National Academy of Sciences of the United States of America 89 (1992), 10837–10841.
229. Tomaselli, S., Galeano, F., Locatelli, F., Gallo, A., ADARs and the balance game between virus infection and innate immune cell response. Current Issues in Molecular Biology 17 (2015), 37–51.
230. van der Oost, J., Westra, E.R., Jackson, R.N., Wiedenheft, B., Unravelling the structural and mechanistic basis of CRISPR-Cas systems. Nature Reviews. Microbiology 12 (2014), 479–492.
231. Vasu, K., Nagaraja, V., Diverse functions of restriction-modification systems in addition to cellular defense. Microbiology and Molecular Biology Reviews: MMBR 77 (2013), 53–72.
232. Venkataraman, T., Valdes, M., Elsby, R., Kakuta, S., Caceres, G., Saijo, S., et al. Loss of DExD/H box RNA helicase LGP2 manifests disparate antiviral responses. Journal of Immunology 178 (2007), 6444–6455.
233. Vollmer, J., Tluk, S., Schmitz, C., Hamm, S., Jurk, M., Forsbach, A., et al. Immune stimulation mediated by autoantigen binding sites within small nuclear RNAs involves Toll-like receptors 7 and 8. The Journal of Experimental Medicine 202 (2005), 1575–1585.
234. Vosberg, H.P., Eckstein, F., Incorporation of phosphorothioate groups into fd and phi X174 DNA. Biochemistry 16 (1977), 3633–3640.
235. Wagner, R.W., Smith, J.E., Cooperman, B.S., Nishikura, K., A double-stranded RNA unwinding activity introduces structural alterations by means of adenosine to inosine conversions in mammalian cells and Xenopus eggs. Proceedings of the National Academy of Sciences of the United States of America 86 (1989), 2647–2651.
236. Wang, X.H., Aliyari, R., Li, W.X., Li, H.W., Kim, K., Carthew, R., et al. RNA interference directs innate immunity against viruses in adult Drosophila. Science 312 (2006), 452–454.
237. Wang, Y., Ludwig, J., Schuberth, C., Goldeck, M., Schlee, M., Li, H., et al. Structural and functional insights into 5'-ppp RNA pattern recognition by the innate immune receptor RIG-I. Nature Structural & Molecular Biology 17 (2010), 781–787.
238. Weber-Gerlach, M., Weber, F., Standing on three legs: Antiviral activities of RIG-I against influenza viruses. Current Opinion in Immunology 42 (2016), 71–75.
239. Wiemann, B., Starnes, C.O., Coley's toxins, tumor necrosis factor and cancer research: A historical perspective. Pharmacology & Therapeutics 64 (1994), 529–564.
240. Wu, L., Cellular and biochemical mechanisms of the retroviral restriction factor SAMHD1. ISRN Biochemistry, 2013, 2013, 728392.
241. Wu, B., Hur, S., How RIG-I like receptors activate MAVS. Current Opinion in Virology 12 (2015), 91–98.
242. Wu, J., Sun, L., Chen, X., Du, F., Shi, H., Chen, C., et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339 (2012), 826–830.
243. Yamamoto, S., Kuramoto, E., Shimada, S., Tokunaga, T., In vitro augmentation of natural killer cell activity and production of interferon-alpha/beta and -gamma with deoxyribonucleic acid fraction from mycobacterium bovis BCG. Japanese Journal of Cancer Research: Gann 79 (1988), 866–873.
244. Yamamoto, S., Yamamoto, T., Kataoka, T., Kuramoto, E., Yano, O., Tokunaga, T., Unique palindromic sequences in synthetic oligonucleotides are required to induce IFN [correction of INF] and augment IFN-mediated [correction of INF] natural killer activity. Journal of Immunology 148 (1992), 4072–4076.
245. Yamamoto, S., Yamamoto, T., Shimada, S., Kuramoto, E., Yano, O., Kataoka, T., et al. DNA from bacteria, but not from vertebrates, induces interferons, activates natural killer cells and inhibits tumor growth. Microbiology and Immunology 36 (1992), 983–997.
246. Yang, Y.G., Lindahl, T., Barnes, D.E., Trex1 exonuclease degrades ssDNA to prevent chronic checkpoint activation and autoimmune disease. Cell 131 (2007), 873–886.
247. Yang, K., Samanta, H., Dougherty, J., Jayaram, B., Broeze, R., Lengyel, P., Interferons, double-stranded RNA, and RNA degradation. Isolation and characterization of homogeneous human (2'-5')(a)n synthetase. The Journal of Biological Chemistry 256 (1981), 9324–9328.
248. Yasuda, T., Takeshita, H., Iida, R., Nakajima, T., Hosomi, O., Nakashima, Y., et al. Molecular cloning of the cDNA encoding human deoxyribonuclease II. The Journal of Biological Chemistry 273 (1998), 2610–2616.
249. Yasutomo, K., Horiuchi, T., Kagami, S., Tsukamoto, H., Hashimura, C., Urushihara, M., et al. Mutation of DNASE1 in people with systemic lupus erythematosus. Nature Genetics 28 (2001), 313–314.
250. Yoneyama, M., Kikuchi, M., Matsumoto, K., Imaizumi, T., Miyagishi, M., Taira, K., et al. Shared and unique functions of the DExD/H-box helicases RIG-I, MDA5, and LGP2 in antiviral innate immunity. Journal of Immunology 175 (2005), 2851–2858.
251. Yoshida, H., Okabe, Y., Kawane, K., Fukuyama, H., Nagata, S., Lethal anemia caused by interferon-beta produced in mouse embryos carrying undigested DNA. Nature Immunology 6 (2005), 49–56.
252. Yu, P., Lubben, W., Slomka, H., Gebler, J., Konert, M., Cai, C., et al. Nucleic acid-sensing Toll-like receptors are essential for the control of endogenous retrovirus viremia and ERV-induced tumors. Immunity 37 (2012), 867–879.
253. Zambon, R.A., Vakharia, V.N., Wu, L.P., RNAi is an antiviral immune response against a dsRNA virus in Drosophila melanogaster. Cellular Microbiology 8 (2006), 880–889.
254. Zhou, R., Rana, T.M., RNA-based mechanisms regulating host-virus interactions. Immunological Reviews 253 (2013), 97–111.
255. Zhu, J., Zhang, Y., Ghosh, A., Cuevas, R.A., Forero, A., Dhar, J., et al. Antiviral activity of human OASL protein is mediated by enhancing signaling of the RIG-I RNA sensor. Immunity 40 (2014), 936–948.
256. Zilberstein, A., Kimchi, A., Schmidt, A., Revel, M., Isolation of two interferon-induced translational inhibitors: A protein kinase and an oligo-isoadenylate synthetase. Proceedings of the National Academy of Sciences of the United States of America 75 (1978), 4734–4738.